{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:40:06Z","timestamp":1756748406670,"version":"3.44.0"},"reference-count":21,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2020,5,25]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Compare the detection rates of the 2013 Philippine Academy of Ophthalmology (PAO) guidelines for retinopathy of prematurity (ROP) screening and the 2005 PAO-Philippine Pediatric Society guidelines in identifying infants who develop ROP in the 5-year study period in the Philippine General Hospital (PGH). Secondary objectives include determination of ROP prevalence; correlation of gestational age (GA), birth weight (BW) and other risk factors to ROP; and identification of the most common intervention.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>Retrospective cross-sectional study of ROP records between 1 December 2013 and 30 November 2018 from the Medical Retina Service of the Department of Ophthalmology and Visual Sciences of the institution was studied. Variables with p value &lt;0.05 were considered significant. STATA V.14 was used for all analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only 851 of 898 infants screened for ROP were included in the study. Of these 698 would have been screened based on 2005 guidelines. All 118 infants with ROP were identified by both guidelines. Detection rate was higher using the 2005 than the 2013 guidelines (16.9% vs 13.3%, p value=0.0496). ROP prevalence was 9.7%. Among those with ROP, 70% have at least one identified risk factor, topped by sepsis, pneumonia, hyaline membrane disease, blood transfusion and oxygen supplementation. Only 8% required intervention consisting of laser, anti-vascular endothelial growth factor injection, surgery or in combination.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In PGH, no infants with ROP were missed using the 2005 recommendations. There was no added benefit of increasing threshold for BW and GA as recommended by the 2013 PAO guidelines. Screening guidelines should, however, be tailored to institutional needs, requirements and experience.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2020-000448","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T17:00:29Z","timestamp":1603213229000},"page":"e000448","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the detection rates for retinopathy of prematurity (ROP) of the 2013 Philippine Academy of Ophthalmology (PAO) Revised Philippine Guidelines and the 2005 PAO-Philippine Pediatric Society (PPS) Guidelines for ROP screening in the Philippine General Hospital: a 5-year review"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9345-2898","authenticated-orcid":false,"given":"Jose Antonio Tan","family":"Paulino","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila, Metro Manila, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2917-5683","authenticated-orcid":false,"given":"Alvina Pauline Dy","family":"Santiago","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila, Metro Manila, Philippines"},{"name":"Philippine Eye Research Institute, Manila, Philippines"},{"name":"UP College of Medicine - University of the Philippines - Manila, Manila, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-4241","authenticated-orcid":false,"given":"Darby Espiritu","family":"Santiago","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila, Metro Manila, Philippines"},{"name":"UP College of Medicine - University of the Philippines - Manila, Manila, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"unstructured":"Recommended Philippine guidelines for screening and referral of retinopathy of prematurity (ROP), 2013. Available: http:\/\/www.pao.org.ph\/news_home\/dec2013\/2013%20ROP%20GUIDELINES%20ver.112613.pdf [Accessed 28 Aug 2018].","key":"2025090110065298000_5.1.e000448.1"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.2","DOI":"10.1136\/bjo.86.6.696"},{"key":"2025090110065298000_5.1.e000448.3","first-page":"937","article-title":"The incidence of visual impairment due to ROP and concomitant disabilities in the Netherlands: a thirty year review","volume":"95","author":"Von Sorge","year":"2011","journal-title":"BMJ Open Ophth"},{"unstructured":"American Academy of Ophthalmology . Retinopathy of prematurity \u2013 Asia Pacific. Available: https:\/\/www.aao.org\/topic-detail\/retinopathy-of-prematurity--asia-pacific#top [Accessed 28 Aug 2018].","key":"2025090110065298000_5.1.e000448.4"},{"unstructured":"Luz JR , Banzon M . 4-Year prevalence and outcome of initial screening for retinopathy of prematurity in a tertiary hospital. Available: http:\/\/paojournal.com\/vol38no2\/vol38no2\/article-list.php?id=6 [Accessed 21 Aug 2018].","key":"2025090110065298000_5.1.e000448.5"},{"unstructured":"Del Mundo PS , Chua CEM . Causes of blindness and severe visual impairment among children enrolled in an early intervention and preschool program of a school for the blind in the Philippines, 2019. Available: https:\/\/docplayer.net\/22403728-Paul-samuel-v-del-mundo-md-carlos-emmanuel-m-chua-md.html","key":"2025090110065298000_5.1.e000448.6"},{"doi-asserted-by":"crossref","unstructured":"Shulman SA . Current screening and treatments in retinopathy of prematurity in the US. Dove Press, 2016: 37\u201343. https:\/\/www.dovepress.com\/current-screening-and-treatments-in-retinopathy-of-prematurity-in-the-peer-reviewed-fulltext-article-EB","key":"2025090110065298000_5.1.e000448.7","DOI":"10.2147\/EB.S94439"},{"unstructured":"Corpus KJ , Anzures JM , Bascuna RI . Proposed new retinopathy of prematurity screening criteria: evidence for including older and heavier Filipino premature babies. Philipp J Ophthalmol 2013;38. Available: https:\/\/paojournal.com\/article\/proposed-new-retinopathy-of-prematurity-screening-criteria-evidence-for-including-older-and-heavier-filipino-premature-babies\/","key":"2025090110065298000_5.1.e000448.8"},{"key":"2025090110065298000_5.1.e000448.9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.semperi.2019.05.001","article-title":"Retinopathy of prematurity \u2013 a world update","volume":"43","author":"Darlow","year":"2019","journal-title":"Semin Perinatol"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.10","DOI":"10.1542\/peds.2005-2749"},{"key":"2025090110065298000_5.1.e000448.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000448","article-title":"Systematic review of mydriatics used for screening of retinopathy in premature infants","volume":"3","author":"Kremer","year":"2019","journal-title":"BMJ Paediatr Open"},{"unstructured":"Mesina-Bayana MA , Arroyo MH . The pressor and mydriatic effects of tropicamide-phenlyephrine combination, plain tropicamide, and plain phenylephrine. A randomized control trial. Philipp J Ophthalmol 2005;30. Available: https:\/\/paojournal.com\/article\/the-pressor-and-mydriatic-effects-of-tropicamide-phenylephrine-combination-plain-tropicamide-and-plain-phenylephrine\/","key":"2025090110065298000_5.1.e000448.12"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.13","DOI":"10.1001\/archopht.121.12.1684"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.14","DOI":"10.1001\/archopht.123.7.991"},{"key":"2025090110065298000_5.1.e000448.15","first-page":"15","article-title":"Criteria for the timing of the initial retinal examination to screen for retinopathy of prematurity","volume":"35","author":"Arroyo","year":"2010","journal-title":"Philipp J Ophthalmol"},{"unstructured":"Cerdana HG , Liao CS , Macias III EL . Results of initial screening for retinopathy of prematurity at a tertiary hospital. Philipp J Ophthalmol 2010;35:56\u201360. Available: https:\/\/paojournal.com\/article\/results-of-initial-screening-for-retinopathy-of-prematurity-at-a-tertiary-hospital\/","key":"2025090110065298000_5.1.e000448.16"},{"key":"2025090110065298000_5.1.e000448.17","first-page":"61","article-title":"Status of screening for retinopathy of prematurity in a tertiary hospital","volume":"35","author":"Ladores","year":"2010","journal-title":"Philipp J Ophthalmol"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.18","DOI":"10.1542\/peds.2004-1180"},{"unstructured":"Lazo MSO , Corpus-Velasquez KD . Maternal and infantile risk factor profile of preterm infants screened for retinopathy of prematurity in a tertiary hospital. Philipp J Ophthalmol;43.","key":"2025090110065298000_5.1.e000448.19"},{"doi-asserted-by":"publisher","key":"2025090110065298000_5.1.e000448.20","DOI":"10.1016\/j.survophthal.2018.04.002"},{"doi-asserted-by":"crossref","unstructured":"Chan DFF , Herrera-Arroyo MM . Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines. BMC Res Notes 2019;12.doi:10.1186\/s13104-019-4303-3","key":"2025090110065298000_5.1.e000448.21","DOI":"10.1186\/s13104-019-4303-3"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2020-000448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:07:01Z","timestamp":1756746421000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2020-000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,20]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bmjophth-2020-000448"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2020-000448","relation":{},"ISSN":["2397-3269"],"issn-type":[{"type":"electronic","value":"2397-3269"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}